Alnylam Pharmaceuticals Cash Flow Statement (2009-2026) | ALNY

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Jun2009 Sep2009 Dec2009 Mar2010 Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-204.51M-258.46M-240.34M-277.40M-405.92M-207.49M-174.10M-276.02M147.75M-137.87M-65.94M-16.89M-111.57M-83.76M-18.25M-66.28M292.68M111.55M205.99M164.49M
Share-based Compensation (Quarter)
33.37M44.58M29.29M30.47M128.12M42.77M39.95M75.80M63.94M41.99M0.77M133.86M45.80M-171.13M9.83M-1.29M268.07M71.63M70.15M86.62M
Deferred Taxes (Quarter)
0.45M0.34M-0.16M-107.39M9.64M9.73M5.60M-27.17M9.31M2.66M
Cash from Operations (Quarter)
-134.04M-150.14M-171.19M-122.82M-115.28M-131.98M-166.47M-58.99M359.41M-29.80M-81.52M124.16M43.71M-94.66M-120.31M155.73M325.11M163.56M70.50M326.72M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter)
Change in Working Capital
Change in Receivables (Quarter)
-3.67M59.45M-39.70M-6.40M38.42M53.27M-19.15M2.97M107.99M-3.87M-0.41M-9.64M37.09M59.51M7.43M136.91M399.86M-184.25M110.42M31.60M
Change in Inventory (Quarter)
13.63M10.76M-1.93M9.20M7.88M18.98M0.40M-1.99M-4.79M-11.99M-0.02M-6.79M-5.92M-0.85M-6.21M-11.14M-4.98M13.86M3.32M-0.28M
Change in Account Payables (Quarter)
Change in Accured Expenses (Quarter)
46.36M39.50M-48.74M68.14M69.75M102.62M-81.97M82.74M118.74M-38.67M-4.87M74.47M83.59M-62.11M-157.74M184.15M223.51M-174.85M-176.03M61.62M
Change in Taxes (Quarter)
Other Working Capital Changes (Quarter)
18.14M-16.67M29.85M21.31M-3.96M-8.69M1.24M27.87M3.32M-23.40M75.46M-61.69M8.28M-25.28M32.77M-6.78M20.74M70.99M6.32M59.37M
Investing Activities
Capital Expenditures (Quarter)
26.06M-40.89M17.86M16.05M-27.76M65.90M13.89M15.92M17.09M-43.10M2.24M-1.18M24.12M9.09M8.97M14.29M-13.66M49.09M21.83M34.68M
Change in Acquisitions & Divestments (Quarter)
-750.00M16.00M505.22M-481.00M1,602.62M-1536.90M49.23M708.54M-699.29M365.47M-307.59M1,070.78M-1070.78M524.38M-466.31M1,522.14M-1520.44M213.19M272.80M
Cash from Investing Activities (Quarter)
-88.27M-413.40M-147.42M142.79M313.89M-139.91M-76.22M-8.71M-10.76M-240.66M-67.62M33.94M-30.25M-52.91M113.77M-141.38M501.11M-37.17M-25.54M-363.46M
Financing Activities
Other financing activities (Quarter)
207.48M45.04M7.83M7.83M7.83M235.86M42.37M49.39M24.80M30.89M25.86M132.78M108.04M36.28M130.59M77.74M41.70M-0.01M33.56M
Cash from Financing Activities (Quarter)
573.84M292.29M34.96M30.34M297.02M63.44M46.37M53.39M33.14M39.23M28.91M131.50M102.75M31.00M46.08M51.76M-448.35M45.32M15.71M36.24M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
Additional items
Exchange Rate Effect (Quarter)
-3.14M-3.05M-2.24M-8.84M2.02M1.62M2.18M-0.13M-6.55M10.90M-9.94M-3.12M15.09M-17.27M14.06M27.51M-0.93M-5.70M-7.06M-2.44M
Change in Cash (Quarter)
348.39M-274.31M-285.89M41.48M497.65M-206.83M-194.15M-14.44M375.23M-220.33M-130.16M286.47M131.31M-133.85M53.60M93.61M376.94M166.00M53.61M-2.94M
Free Cash Flow (Quarter)
-160.10M-109.25M-189.05M-138.87M-87.53M-197.88M-180.37M-74.91M342.32M13.30M-83.76M125.34M19.59M-103.76M-129.28M141.44M338.77M114.46M48.67M292.04M
Net Cash Flow (Quarter)
351.53M-271.25M-283.66M50.31M495.63M-208.45M-196.32M-14.30M381.79M-231.22M-120.22M289.59M116.21M-116.58M39.54M66.11M377.87M171.71M60.68M-0.50M